Login / Signup

Resveratrol-loaded Microemulsion Based Thermosensitive Hydrogel for Potential Topical Treatment of the Vaginal Inflammation.

Jiaxin LiuLiuqi ZhouHuijing CongJing HuJing-Ling Tang
Published in: Journal of drug targeting (2024)
Vaginal inflammation is a prevalent gynecological condition. If left untreated, it can potentially spread to the urinary and reproductive systems. In this study, we propose a resveratrol-loaded microemulsion-based thermosensitive hydrogel (Res-Me-Tsgel) and compare it with a chitosan hydrogel-based Res-Me-Cogel. The Res-Me-Tsgel we prepared is a transparent liquid solution at room temperature that rapidly forms a gel at 37 °C. Compared to Res solution and Res-Me, both Res-Me-Cogel and Res-Me-Tsgel demonstrate superior sustained release properties. Both in vitro and in vivo studies confirm the excellent biosafety profile of Res-Me-Cogel and Res-Me-Tsgel. Vaginal administration of these formulations in rats results in prolonged retention of resveratrol within the vagina. Notably, due to its improved flow into vaginal folds after administration, the retention of Resveratrol was approximately three times higher for the Res-Me-Tsgel group compared to the Res-Me-Cogel group at 24 h post-administration. Overall, these findings highlight the potential application of Res-Me-Tsgel as an effective means for vaginal inflammation.
Keyphrases
  • drug delivery
  • wound healing
  • oxidative stress
  • room temperature
  • hyaluronic acid
  • ionic liquid
  • risk assessment
  • cancer therapy
  • climate change
  • human health
  • combination therapy